1 active not recruiting, 1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow anisodine: new trials by email Literature Review of anisodine trials Research Report on anisodine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) Anisodine Hydrobromide, Anisodine Hydrobromide Placebo - Acute Ischemic Stroke | Phase 2 | Recruiting | Capital Medical University | 204 | 2026-09-06 | 2026-10-13 |
| Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) Anisodine Hydrobromide - Acute Ischemic Stroke | Phase 1 | Active not recruiting | Capital Medical University | 92 | 2026-04-28 | 2026-08-24 |
| Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine Anisodine Hydrobromide, Anisodine Hydrobromide placebo - Migraine Without Aura, Migraine With Aura | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 288 | 2023-10-30 | 2024-02-28 |
Ischemic Stroke (2) · Stroke (2) · Migraine Disorders (1) · Migraine with Aura (1) · Migraine without Aura (1)
Capital Medical University (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (3)
PMID 22590713, PMID 23731663, PMID 24524844, PMID 30353868, PMID 30496104, PMID 30879893, PMID 32430657